Free Trial

Geode Capital Management LLC Buys 28,284 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Addus HomeCare logo with Medical background

Geode Capital Management LLC lifted its position in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 7.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 423,934 shares of the company's stock after buying an additional 28,284 shares during the period. Geode Capital Management LLC owned about 2.34% of Addus HomeCare worth $56,406,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Point72 Asset Management L.P. lifted its position in Addus HomeCare by 73.4% in the 2nd quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company's stock valued at $86,598,000 after acquiring an additional 315,602 shares in the last quarter. Millennium Management LLC lifted its holdings in shares of Addus HomeCare by 412.7% during the second quarter. Millennium Management LLC now owns 316,418 shares of the company's stock valued at $36,739,000 after purchasing an additional 254,705 shares in the last quarter. Wasatch Advisors LP boosted its position in shares of Addus HomeCare by 11.8% during the third quarter. Wasatch Advisors LP now owns 1,043,240 shares of the company's stock valued at $138,782,000 after buying an additional 110,010 shares during the last quarter. Ghisallo Capital Management LLC bought a new stake in Addus HomeCare in the 2nd quarter worth about $11,611,000. Finally, Principal Financial Group Inc. raised its position in Addus HomeCare by 17.5% in the 3rd quarter. Principal Financial Group Inc. now owns 505,853 shares of the company's stock worth $67,293,000 after buying an additional 75,409 shares during the last quarter. Hedge funds and other institutional investors own 95.35% of the company's stock.

Insider Activity

In other news, CEO R Dirk Allison sold 12,500 shares of the firm's stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the completion of the transaction, the chief executive officer now owns 141,897 shares in the company, valued at $17,476,034.52. This trade represents a 8.10 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Roberton James Stevenson sold 2,250 shares of Addus HomeCare stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $121.00, for a total value of $272,250.00. Following the completion of the sale, the executive vice president now directly owns 10,217 shares in the company, valued at approximately $1,236,257. The trade was a 18.05 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 4.60% of the company's stock.

Addus HomeCare Price Performance

Shares of NASDAQ:ADUS traded down $2.54 during mid-day trading on Monday, reaching $128.86. 134,949 shares of the company traded hands, compared to its average volume of 134,800. The company's 50 day moving average price is $125.86 and its 200-day moving average price is $125.14. The firm has a market cap of $2.34 billion, a PE ratio of 29.49, a PEG ratio of 2.11 and a beta of 1.01. Addus HomeCare Co. has a 52 week low of $85.94 and a 52 week high of $136.12.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, topping analysts' consensus estimates of $1.28 by $0.02. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business had revenue of $289.80 million during the quarter, compared to analyst estimates of $289.42 million. During the same period in the prior year, the business posted $1.03 earnings per share. The company's revenue was up 7.1% on a year-over-year basis. On average, research analysts predict that Addus HomeCare Co. will post 4.59 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have recently issued reports on ADUS. JMP Securities began coverage on shares of Addus HomeCare in a report on Monday, December 16th. They set an "outperform" rating and a $150.00 price target on the stock. Stephens lifted their target price on shares of Addus HomeCare from $143.00 to $145.00 and gave the stock an "overweight" rating in a research report on Wednesday, November 6th. KeyCorp initiated coverage on Addus HomeCare in a report on Friday, October 11th. They set an "overweight" rating and a $150.00 price target on the stock. StockNews.com raised Addus HomeCare from a "hold" rating to a "buy" rating in a report on Wednesday, December 11th. Finally, Citizens Jmp upgraded Addus HomeCare to a "strong-buy" rating in a research report on Monday, December 16th. One investment analyst has rated the stock with a sell rating, nine have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Buy" and a consensus target price of $133.67.

Get Our Latest Stock Analysis on ADUS

Addus HomeCare Company Profile

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Read More

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Should You Invest $1,000 in Addus HomeCare Right Now?

Before you consider Addus HomeCare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.

While Addus HomeCare currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025
Investing in Quantum Computing: Is Rigetti the Stock to Watch?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines